Abstracts (HTML) List of Authors

Ochel, A

Function of hepatic type 2 innate lymphoid cells is regulated by liver inflammation-induced cytokines and effector CD4 T cells
IL-33 regulates immune-mediated hepatitis by induction of M2 macrophages and ST2 Tregs

Odenthal, M

The lysine-specific histone demethylase LSD1 controls cell cycle progression in liver fibrosis and cancer by alteration of protein expression profiles
The lysine specific histone demethylase LSD1 in activated Hepatic Stellate Cells contributes to liver fibrosis
The epigenetic writer LSD1 controls hepatic cell cycle progression by alteration of global expression profiles and protein signatures

Oenarto, J

Taurine deficiency induces hyperammonemia and oxidative stress and senescence in mouse liver

Oo, Y

Autoimmune hepatitis with normal IgG at diagnosis: Subtype without selective elevation of IgG but similar histological features and treatment response

Ori, A

Ganglioside GM2 activator (GM2A) is as a novel pro-survival p53 target in hepatocellular carcinoma

Orlinger, K

rLCMV vectors elicit tumour directed immune responses, inhibit tumour progression and prolong survival of mice

Ostroumov, D

Investigation of exhausted tumor-specific CD8 T cells in orthotopic hepatocellular carcinoma mouse model
rLCMV vectors elicit tumour directed immune responses, inhibit tumour progression and prolong survival of mice

Othman, A

Identification of metabolic prognostic biomarkers in carbon tetrachloride-induced liver fibrosis using MAS-H1-NMR

Ott, M

An “all in one” CRISPR/Cas9 AAV corrects the genetic defect in mice mimicking human Tyrosinemia Type 1 disease

Otto, T

Deletion of MyD88 in non-parenchymal cells, but not in parenchymal cells attenuates the progression of hepatocellular carcinoma

Ozga, A

Anti-HEV seroprevalence rate in the Americas